Verified email-pattern data for Pharmakon Press is currently limited. You can still use the company insights and contact sections below.
The Journal 'Review of Clinical Pharmacology and Pharmacokinetics-International Edition' (abbreviated title: Rev. Clin. Pharmacol. Pharmacokinet., Int. Ed.) founded in 1987 aims to promote optimum drug therapy by providing original papers and review articles covering important aspects of clinical and applied Pharmacology and Therapeutics, Medicine and Surgery. It became an open access journal in September 2023.
The Journal includes drug evaluation reviews providing a detailed focus on different properties, i.e. dosage, toxicology, drugs interactions and place in therapy of both newer and established drugs. Other Review Articles offer state-of-the-art literature surveys covering broader topics. Practical Therapeutics Articles and Leading Articles provide recommendations for specific situations of connections or emerging areas, respectively.
The journal publishes:
• Original paper
• Research Article
• Review article
• Case study
• Clinical study
• Literature review
• Statistical study
The scientific standard of the papers, which are accepted for publication, is controlled by the Editorial Board or by other Experts in the various fields of Pharmacology, Pharmacokinetics and Therapeutics Medicine and Surgery.
Submitted papers are subject to a rigorous but rapid peer review process. A first decision is provided to authors approximately in a week after submission and we aim for a review time of two weeks. Acceptance for publication is approximately in 4 weeks. Faster Publication in PHARMAKON- Press’s open access journal is achieved by online availability.
The review process is designed to help authors to improve their articles by giving them constructive comments, and we select to publish only those articles which comply to general quality criteria of a scholarly paper, especially originality, clarity, references to related work and validity of results and conclusions.
Company Details
- Founded
- -
- Address
- Estias 6-8, Athens,greece
- Industry
- Book And Periodical Publishing
- Website
- http://www.pharmakonpress.gr
- HQ
- Athens
- Competitors
- EIRENE RI | Environmental Exposure Assessment Research Infrastructure, SUSTCHEM S.A., DNAlogy S.A., Benaki Phytopathological Institute (BPI), International Human Exposome Network, DNA Therapeutics, IATROPOLIS Medical Group, Hellamco S.A Scientific Instruments, The Crime Lab, Bioiatriki Healthcare Group.
Pharmakon Press Questions
PHARMAKON PRESS's website is http://www.pharmakonpress.gr
PHARMAKON PRESS's LinkedIn profile is https://gr.linkedin.com/company/pharmakon-press
PHARMAKON PRESS's industry is
Book and Periodical Publishing
PHARMAKON PRESS's top competitors are
Eirene Ri | Environmental Exposure Assessment Research Infrastructure,
Sustchem S.a.,
Dnalogy S.a.,
Benaki Phytopathological Institute (Bpi),
International Human Exposome Network,
Dna Therapeutics,
Iatropolis Medical Group,
Hellamco S.a Scientific Instruments,
The Crime Lab,
Bioiatriki Healthcare Group.
PHARMAKON PRESS's categories are Book and Periodical Publishing
PHARMAKON PRESS's founding year is 1983
Explore related pages
Related company profiles:
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.